Dapsone is a drug commonly used in the treatment of leprosy. In Europe it is rarely prescribed, mostly for the treatment of skin diseases such as dermatitis herpetiformis. Poisoning with dapsone is rare and reports of such cases are of interest for toxicological practice. We describe the only acute dapsone poisoning in a caseload series of 21000 intoxications treated in the Clinical Toxicology Clinic at St George University Hospital in Plovdiv, Bulgaria between 1999 and 2013. We report on a 36-year-old woman who attempted deliberate self-poisoning with an ingestion of approximately 4.5 g of dapsone and 0.3 g of olanzapine. On admission, the patient was in a state of severe intoxication and comatose. On admission to hospital 9 hours after the ingestion, the methemoglobin level was 51.7%. The patient recovered 8 days later. She received complex treatment including intubation, ventilation, repeated gastric lavage, hemodialysis, blood exchange transfusion and antidote treatment with methylene blue. She was discharged in good clinical condition with minimal organ damage such as mild toxic hepatitis. 
INTRODUCTION
Dapsone belongs to a class of drugs known as sulfones. It was fi rst introduced in 1943 as an effective chemotherapeutic agent and is still an important drug in the multidrug therapy of leprosy 1, 2 , in some skin diseases e.g. dermatitis herpetiformis, acne vulgaris, psoriasis and immunosuppression-induced pulmonary infections caused by Pneumocystis carinii and Toxoplasma gondii. Acute poisoning from excessive dapsone intake is uncommon in Europe. 3 Description of similar cases could be of great interest to toxicological practice. The reported case is the only acute severe dapsone poisoning in a caseload of 21000 consecutive intoxications treated in the Clinical Toxicology Clinic at St George University hospital, Plovdiv, Bulgaria, between 1999 and 2013. 6 -Dapsone is potent high plasma protein binding agent and has high apparent volume of distribution. 7 -There is an insuffi cient renal excretion of un- 
CASE REPORT

A 37-year-old Caucasian woman (E.S.D, hospital
cal strain and was entitled to two free follow-up evaluations from toxicologist up to 30 days after discharge simultaneous with the follow up from a psychiatrist.
DISCUSSION
Dapsone is well known to produce methemoglobinemia, hemolytic anemia, and less often agranulocytosis, peripheral neuropathy, psychoses, hepatotoxicity and renal toxicity. 4 Overdosed dapsone can cause severe methemoglobinemia, hemolysis and even death (methemoglobinemia > 30-70%), depending on the ingested quantity or individual susceptibility. 1, 3, 5 Toxicologically, some of the characteristics of dapsone are important and should be taken into consideration for the diagnosis and the appropriate treatment: -Dapsone is a bitter lipid-soluble compound with effective penetration of tissues and cells. -Dapsone is well-absorbed when ingested.
changed dapsone -about 20% of the administered dose 8 , so forced dieresis is not the only method of choice for decontamination in overdose.
-The therapeutic index of dapsone is considered to be quite narrow so it easily may act as a poisonous substance.
-Clinical manifestation of dapsone acute poisoning is based on the methemoglobinemia effects and functional anemia and resembles the toxic result of congenital defi ciency of red cell NADH reductase or toxic response to chlorates, inorganic and organic nitrites, local anesthetics and other sulpha drugs 1 , so that all these should be distinguished.
DIAGNOSIS
There is no diffi culty in diagnosing acute dapsone poisoning in emergency in presence of positive evidence such as rapid onset of symptoms, progressive worsening of the general condition, cyanosis, tachycardia, impairment of consciousness, vomit-ing, brown color of blood and missing pills from the dapsone drug container. MetHb concentration exceeding 15% combined with cyanosis, fatigue, dizziness and headache usually associates with mild intoxication. 9, 10 In the case we report the clinical fi ndings -coma, tachycardia and severe cyanosis -correspond to the MetHb level of 51.7%, and is associated with severe acute intoxication. 9, 10 DOSE AND SEVERITY To develop an appropriate therapeutic plan, it is very important to have an accurate estimate of the ingested quantity of the drug. There are reports of dapsone ingestion ranging from 200 mg to 10 g 1,11-14 , associated with acute poisoning, toxic level of MetHb and clinical symptoms, while two patients with MetHb level of greater than 50% was measured in each case, however, both patients were conscious and talking on presentation. 9 In our case the patient's depressed consciousness was due to the combined toxic effect of dapsone and olanzapine overdose.
If there is no information about the ingested amount, the absorbed dapsone (dapsonemia) can be calculated using the formula: Dapsonemia = 12.9256 -0.0682t + 0.234 MetHbnemia, where t is the time elapsed from ingestion to testing. 5 In our case the dapsonemia was 24.4096 μg/ ml, which was consistent with severe dapsone intoxication due to effective absorption of 17-19 tablets of the drug. We can hypothesize that the initial gastric lavage and charcoal administration in the emergency room had reduced the toxic drug load approximately to 50%. This is in support of the conclusion of Carrazza MN, et al. that a mathematical model allows a good estimate of DDS (dapsone) level, since the MetHb-emia values and the time elapsed after dapsone intake are known. 5 OLANZAPIN INVOLVEMENT Olanzapine has been studied as an antiemetic drug, particularly for management of chemotherapyinduced nausea and vomiting. 15 Acute olanzapine overdose is predominantly associated with anticholinergic symptoms and central nervous system depression, meiosis and unpredictable fl uctuations between somnolence/coma and agitation/ aggression. 16 Lethal outcomes have been reported after an acute overdose of 450 mg, but there are reports of survival after an acute overdose of 2000 mg. 17 In the reported case olanzapine overdose of 300 mg contributed to the rapid onset of coma, suppression of vomiting and motor activity; repeated charcoal, gastric lavage and veno-venous hemodialysis of the metabolites enhanced the elimination of the toxic drug load.
CONCLUSIONS
Early detection of dapsone poisoning and prompt use of all known therapeutic techniques are factors that can greatly benefi t patients. Gastric lavage and activated charcoal may reduce the effects of toxic overdose by up to 50% if administered as soon as possible after ingestion of dapsone. The mathematical model of Carrazza M et al. allows us to make a good estimate of dapsone plasma level, since the MetHb-emia values and the time elapsed after intake are known.
